Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.34 |
| ▸ | PIM1 | P11309 | 2/20 | 0.32 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.32 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.32 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.32 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19009315 | 0.96 | LIMK1 (0.34) | ALOX5PIM1PIM3PIM2TSHR | |
| SCHEMBL18273091 | 0.96 | ALOX5 (0.34) | ALOX5TSHRPRKDCKDM4E | |
| SCHEMBL19009322 | 0.94 | ALOX5 (0.36) | ALOX5PIM1PIM3PIM2TSHR | |
| SCHEMBL18273101 | 0.92 | ALOX5 (0.32) | ALOX5PIM1PIM3PIM2CSNK2A2 | |
| SCHEMBL18273114 | 0.90 | ALOX5 (0.33) | ALOX5TSHRPRKDC | |
| SCHEMBL18273083 | 0.89 | ALOX5 (0.40) | ALOX5PIM1PIM3PIM2TSHR | |
| SCHEMBL18273138 | 0.89 | ALOX5 (0.33) | ALOX5TSHRPRKDCMAPTKDM4E | |
| SCHEMBL19009279 | 0.89 | ALOX5 (0.32) | ALOX5PIM1PIM3PIM2CSNK2A2 | |
| SCHEMBL25017702 | 0.89 | TSHR (0.30) | TSHR | |
| SCHEMBL18273102 | 0.88 | ALOX5 (0.38) | ALOX5PIM1PIM3PIM2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160351826-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2016-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160351826-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | ALOX5 1855/4885PIM1 3689/4885PIM3 3669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.